|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
6
|
|
pubmed:dateCreated |
2009-8-21
|
|
pubmed:databankReference |
|
|
pubmed:abstractText |
Nucleoside reverse-transcriptase inhibitor (NRTI)-related mitochondrial toxicity has been suggested as a key factor in the induction of antiretroviral-related lipoatrophy. This study aimed to evaluate in vivo the effects of NRTI withdrawal on mitochondrial parameters and body fat distribution.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1537-6591
|
|
pubmed:author |
pubmed-author:Alonso-VillaverdeCarlosC,
pubmed-author:BarrufetPilarP,
pubmed-author:BonjochAnnaA,
pubmed-author:ClotetBonaventuraB,
pubmed-author:CucurullJosepJ,
pubmed-author:DomingoPereP,
pubmed-author:EstanyCarlaC,
pubmed-author:ForceLluísL,
pubmed-author:GarrabouGlòriaG,
pubmed-author:MULTINEKA Study Group,
pubmed-author:MasabeuAngelsA,
pubmed-author:MiróOscarO,
pubmed-author:MorénConstanzaC,
pubmed-author:NegredoEugeniaE,
pubmed-author:Pérez-AlvarezNúriaN,
pubmed-author:Rodríguez-SantiagoBenjamíB
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
49
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
892-900
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:19663689-Absorptiometry, Photon,
pubmed-meshheading:19663689-Adult,
pubmed-meshheading:19663689-Anti-HIV Agents,
pubmed-meshheading:19663689-Antiretroviral Therapy, Highly Active,
pubmed-meshheading:19663689-Body Composition,
pubmed-meshheading:19663689-DNA, Mitochondrial,
pubmed-meshheading:19663689-Drug Therapy, Combination,
pubmed-meshheading:19663689-Electron Transport Complex IV,
pubmed-meshheading:19663689-Extremities,
pubmed-meshheading:19663689-Female,
pubmed-meshheading:19663689-Follow-Up Studies,
pubmed-meshheading:19663689-HIV Infections,
pubmed-meshheading:19663689-HIV-Associated Lipodystrophy Syndrome,
pubmed-meshheading:19663689-Humans,
pubmed-meshheading:19663689-Lipids,
pubmed-meshheading:19663689-Lopinavir,
pubmed-meshheading:19663689-Male,
pubmed-meshheading:19663689-Middle Aged,
pubmed-meshheading:19663689-Nevirapine,
pubmed-meshheading:19663689-Pyrimidinones,
pubmed-meshheading:19663689-Reverse Transcriptase Inhibitors,
pubmed-meshheading:19663689-Ritonavir,
pubmed-meshheading:19663689-Treatment Outcome,
pubmed-meshheading:19663689-Viral Load
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).
|
|
pubmed:affiliation |
Lluita contra la SIDA Foundation, Barcelona, Spain. enegredo@flsida.org
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
